Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185587 · ClinicalTrials.gov registry record

Sodium Channel Splicing in Heart Failure Trial

A clinical trial, sponsored by University of Illinois at Chicago.

Completed
Registry status
147
Enrollment target

NCT01185587: Completed study, sponsored by University of Illinois at Chicago.

NCT01185587 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 147 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185587 has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
147 participants
Enrollment target

Study Summary

The purpose of this research is to see if investigators can detect truncated mRNA splice variants of the cardiac voltage-gated sodium (Na+) channel gene, SCN5A, in patients with a weak heart (Heart Failure) with or without an implantable cardioverter-defibrillator (ICD) and compare them to patients with a normal heart. Hypothesis: 1. Patients with reduced left ventricular ejection fraction have increased abundances truncated mRNA splice variants of the SCN5A gene, which portends to sodium channel dysfunction and an increased risk for sudden cardiac death. 2. Patients with implantable cardioverter-defibrillator devices (ICDs) who have experienced shock therapy have increased abundances of truncated mRNA splice variants of the SCN5A gene compared to similar congestive heart failure patients who have not experienced shock therapy.

Primary Outcome

We will correlate the amount of white cell Na+ channel splice variants with ejection fraction in patients with an without heart failure and with the number of shocks in the patients with ICDs.

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2010-02
Est. Completion 2014-04
University of Illinois at Chicago

430 total trials

What the finished NCT01185587 record still lists

NCT01185587 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01185587 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01185587 about?

NCT01185587 is a clinical study titled "Sodium Channel Splicing in Heart Failure Trial". The purpose of this research is to see if investigators can detect truncated mRNA splice variants of the cardiac voltage-gated sodium (Na+) channel gene, SCN5A, in patients with a weak heart (Heart Failure) with or without an implantable cardioverter-defibrillator (ICD) and compare them to patients ...

What is the current status of trial NCT01185587?

This trial is currently completed. The enrollment target is 147 participants. The study started on 2010-02. Estimated completion is 2014-04.

Who is sponsoring clinical trial NCT01185587?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04396613 · 147 participants · NA

    Wound Closure Techniques in Primary Spine Surgery

  • NCT04851119 · 147 participants · Phase 1

    Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NCT05523947 · 147 participants · Phase 1

    Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  • NCT06121843 · 147 participants · Phase 1

    A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01185587, the US trial registry maintained by the National Library of Medicine. NCT01185587 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.